These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Iohexol versus metrizamide for lumbar myelography: preliminary report of double-blind trial.
    Author: Gebarski SS, Gabrielsen TO, Knake JE, Latack JT, Hoff JT.
    Journal: Neurosurgery; 1984 Jan; 14(1):19-21. PubMed ID: 6363962.
    Abstract:
    Lumbar myelography was performed in 38 patients; 19 received iohexol (an investigational aqueous contrast agent) and 19 received metrizamide. Iohexol is stable in solution, which is not the case with metrizamide. There was no other significant difference in diagnostic utility or quality between the two media. However, there was considerable postmyelography morbidity in the metrizamide group, but no postmyelography morbidity in the iohexol group. Preliminary clinical evidence suggests that iohexol is significantly superior to metrizamide as a contrast agent for lumbar myelography.
    [Abstract] [Full Text] [Related] [New Search]